AD is known to be primarily a T cell-driven disease, with a dominant T helper (Th) type 2 immune response with increased levels of IL-4, IL-13, and IL-31 and additional activation of Th22,Th17/I L-23, and Th1 cytokine pathways (2–4). Here, IL4 is linked to Alzheimer disease.